Ipamorelin (5mg)
Spécifications techniques
| Pureté (HPLC) | ≥99% (HPLC) |
| Numéro CAS | 170851-70-4 |
| Forme | White lyophilized powder |
| Stockage | -20°C |
| Séquence | Aib-His-D-2-Nal-D-Phe-Lys-NH₂ |
| Poids moléculaire | 711.85 g/mol |
| Forme saline | Acetate |
| Solubilité | Soluble in water |
Ipamorelin (5mg)
Prix catalogue EUR · HU, SK, CZ, PL
- Eurozone (EUR)45,00 EUR
- Hongrie (HU)45,00 EUR≈ 18 000 Ft
- Slovaquie (SK)45,00 EUR
- Tchéquie (CZ)45,00 EUR≈ 1 125 Kč
- Pologne (PL)45,00 EUR≈ 191,25 zł
Même prix catalogue en EUR pour livraison vers la Hongrie, la Slovaquie, la République tchèque et la Pologne. Paiement en EUR.
Montants HUF/CZK/PLN indicatifs convertis depuis l’EUR ; la Slovaquie utilise l’EUR. Taux approximatifs. Paiement en EUR.
Growth hormone secretagogue. For laboratory research use only.
Strictement réservé à la recherche en laboratoire.
Non destiné à la consommation humaine, vétérinaire ou au diagnostic.
From the Peptide Explorer
A selective growth hormone secretagogue that stimulates GH release via the ghrelin/GHSR-1a receptor without significantly affecting cortisol, ACTH, or prolactin levels. This selectivity distinguishes it from other GHRPs like GHRP-6 and hexarelin.
Key Mechanisms
- ›GHSR-1a (ghrelin receptor) agonism
- ›Selective GH pulse amplification
- ›Minimal cortisol/prolactin elevation
- ›No appetite stimulation (unlike GHRP-6)
- ›Synergy with GHRH analogs
Primary Research Areas
- ›GH secretion
- ›Body composition
- ›Bone density
- ›Age-related GH decline
- ›Selective secretagogue research
Key Research Findings
- Stimulated GH release comparable to GHRP-6 without cortisol or prolactin elevation
- Demonstrated dose-dependent GH release with a wider therapeutic window
- Synergistic GH amplification when combined with CJC-1295
Research Overview
A selective growth hormone secretagogue that stimulates GH release via the ghrelin/GHSR-1a receptor without significantly affecting cortisol, ACTH, or prolactin levels. This selectivity distinguishes it from other GHRPs like GHRP-6 and hexarelin.
Origin: Synthetic pentapeptide GH secretagogue developed by Novo Nordisk
Mechanism of Action
- GHSR-1a (ghrelin receptor) agonism
- Selective GH pulse amplification
- Minimal cortisol/prolactin elevation
- No appetite stimulation (unlike GHRP-6)
- Synergy with GHRH analogs
Primary Research Areas
- GH secretion
- Body composition
- Bone density
- Age-related GH decline
- Selective secretagogue research
Key Published Findings
- Stimulated GH release comparable to GHRP-6 without cortisol or prolactin elevation
- Demonstrated dose-dependent GH release with a wider therapeutic window
- Synergistic GH amplification when combined with CJC-1295
Research Protocol
Commonly studied routes: Subcutaneous. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
-20°C lyophilized, 2-8°C reconstituted
Important Notice
Ipamorelin (5mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Spécifications de recherche
Synthesized for strict analytical consistency. Verified via HPLC/MS.Voir les standards qualité →
Manipulation et stockage
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water